BERLIN, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Synthetic biology startup Cambrium announces €8 Million in Seed financing, led by Essential Capital, along with SNR, Valor Equity Partners, and HOF Capital.
Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules Seed financing will drive commercial growth for Cambrium’s first product, NovaColl™, and accelerate ...
The Berlin-based company brings novel molecules with previously unseen functionalities to life, through a technology platform which combines biology and machine learning to supercharge product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results